Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. reports developments tied to healthcare intelligence, data and analytics technology, and professional services for healthcare organizations. Company updates commonly cover operating results, revenue and Adjusted EBITDA guidance, and the use of AI-driven technology and domain expertise to support health systems across cost, clinical, and consumer performance.
Recurring news also includes leadership and board governance changes, shareholder-related board appointments, investor conference participation, and updates on strategic focus areas for its healthcare data platform, analytics applications, implementation, advisory, outsourcing, and improvement services.
Health Catalyst (HCAT) has announced a stock repurchase of approximately $5 million, executed between March 3-10, 2025. The company retired approximately 1.1 million shares of common stock as part of its existing share repurchase program, which was authorized in August 2022 with a total capacity of $40 million.
CEO Dan Burton stated that the repurchase reflects the company's confidence in its future, citing that current market prices don't reflect their long-term value. The company anticipates continued achievement of operating leverage and revenue growth reacceleration, emphasizing their commitment to creating sustainable value for shareholders, clients, and team members.
Health Catalyst (Nasdaq: HCAT) has entered into a multi-year agreement with Signature Healthcare, an integrated healthcare delivery system in Southeastern Massachusetts. The partnership centers on implementing Health Catalyst Ignite™, a modern data and analytics ecosystem that integrates clinical and claims data while enhancing care coordination.
The solution will enable Signature Healthcare to leverage data insights for supporting quality patient outcomes and optimizing operational performance. The platform integrates best-in-class cross-industry technologies with healthcare-specific data models and self-service tools in a scalable environment.
Robert Haffey, Signature Healthcare's President and CEO, emphasized the alignment between Health Catalyst's solutions and their leadership team's governance objectives. The partnership aims to enhance patient health and wellness while supporting operational excellence, with Health Catalyst providing population health expertise to maximize Ignite's capabilities.
Health Catalyst (HCAT) reported strong financial results for Q4 and full-year 2024, achieving total revenue of $307 million and Adjusted EBITDA of $26 million for 2024. The Technology segment showed notable performance with revenue of $195 million for full-year 2024 and $52 million for Q4 2024, representing 10% year-over-year growth.
The company provided guidance for 2025, projecting total revenue of approximately $335 million, Technology revenue of $220 million, and raised their Adjusted EBITDA target by $2 million to $41 million. For Q1 2025, they expect revenue of approximately $79 million and Adjusted EBITDA of $4 million.
The company announced governance updates, including the appointment of Dr. Jill Hoggard Green to the Board of Directors and the promotion of Dr. Daniel Samarov to Chief AI Officer.
Health Catalyst (HCAT), a leading healthcare data and analytics technology provider, has announced its participation in the Raymond James & Associates' 46th Annual Institutional Investors Conference in Orlando, FL. The company's executive team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will conduct a fireside chat presentation on Tuesday, March 4, 2025, at 1:40 p.m. ET.
Interested parties can access the webcast through Health Catalyst's investor relations website at https://ir.healthcatalyst.com.
Health Catalyst (HCAT) has announced it will release its fourth quarter and full year 2024 operating results on Wednesday, February 26, 2025, after market close. The company will host a conference call at 5:00 pm ET on the same day to review the results. U.S. participants can join by dialing 800-343-5172, while international participants can dial 203-518-9856, using conference ID 'HCATQ424'. A live audio webcast will be available at ir.healthcatalyst.com, with a replay accessible for approximately 90 days after the call.
Health Catalyst (Nasdaq: HCAT) has announced its participation in an upcoming investor conference. The company's leadership team, including Chief Executive Officer Dan Burton, Chief Financial Officer Jason Alger, and Chief Operating Officer Dan LeSueur, will attend the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference. The event is scheduled to take place on February 11, 2025, in Snowbird, UT. Health Catalyst is known for providing data and analytics technology and services to healthcare organizations.
Modern Health has appointed Adam Brown as Chief Financial Officer, strengthening its executive team. Brown brings over fifteen years of healthcare finance experience, most recently serving as Senior VP of Financial Planning & Analysis and Investor Relations at Health Catalyst (NASDAQ: HCAT).
At Health Catalyst, Brown was instrumental in scaling the company from a venture-backed startup to a public company with over $300M in revenue and 1,400+ team members. He managed multiple funding rounds, including the company's IPO, and oversaw six acquisitions. His previous experience includes positions at GTCR's private equity healthcare practice and Bank of America Merrill Lynch's healthcare investment banking group.
The appointment follows Modern Health's recent developments, including a RAND Europe peer-reviewed study on global mental health support engagement and the acquisition of Anvil Health's AI technology.
Health Catalyst (HCAT) has announced a strategic partnership with Databricks to enhance healthcare data sharing and analytics. The collaboration integrates Health Catalyst's Ignite™ platform with Databricks' Delta Sharing technology, creating a configurable solution specifically designed for healthcare organizations.
The partnership combines Health Catalyst's healthcare intelligence, including clinical, financial, operational, and regulatory expertise, with Databricks' technical infrastructure optimized for high-scale data processing. The joint solution leverages healthcare-specific data models and advanced analytics, enabling secure cross-platform data sharing across clouds and regions.
This integration aims to help healthcare organizations accelerate insights and access healthcare-ready data without building complex solutions from scratch, ultimately focusing on improving outcomes and operational efficiency.
Health Catalyst (HCAT) has announced a definitive agreement to acquire Upfront Healthcare Services, a next-generation patient engagement platform provider. The acquisition, expected to close in Q1 2025, will be funded through a mix of cash and stock.
The integration aims to combine Upfront's patient acquisition and scheduling expertise with Health Catalyst's existing patient engagement portfolio, including Twistle Patient Engagement and Lumeon Care Orchestration platform. Upfront's technology analyzes clinical, sociodemographic, and patient-reported data to guide patients to needed care, helping providers reengage patients, promote appointment attendance, and improve care transitions.
The merger will integrate with Health Catalyst Ignite™ Data and Analytics to enhance healthcare clients' ability to provide optimal patient care, focusing on optimizing access, improving care transitions, and closing care gaps.
Health Catalyst (Nasdaq: HCAT) has announced a multi-year partnership with OrthoNebraska, a leading orthopedic care provider based in Omaha, Nebraska. The partnership will leverage Health Catalyst's Ignite™ platform, a comprehensive data and analytics ecosystem designed to enhance patient outcomes, operational efficiency, and personalized patient experiences.
Ignite integrates clinical, financial, and patient experience data into a unified healthcare model, providing OrthoNebraska with a single access point for key performance indicators. This integration will enable OrthoNebraska to make more informed, data-driven decisions through self-service tools and enhanced analytics transparency.
OrthoNebraska's CEO, Levi Scheppers, emphasized that the partnership will simplify and personalize musculoskeletal healthcare by providing near real-time information to specialized teams. Health Catalyst will also offer ongoing operational support, including data source configuration, governance, and security administration.
Health Catalyst's CEO, Dan Burton, highlighted the importance of integrated data for improving patient outcomes and operational performance, noting that the Ignite platform is a scalable, long-term solution tailored for healthcare.